Phage Therapy Checklist

∞ generated and posted on 2020.05.29 ∞

A published checklist of issues relevant to both conducting and reporting on phage therapy experiments.

Please cite as:

Stephen T. Abedon
Phage Therapy Checklist.
checklist.phage-therapy.org

Discussion of each bullet point can be found in Abedon (2017).

Note that though open access, the article's web page has few bookmarks to point links to. Therefore, after landing on the page, use the indicate section numbers to find the appropriate position on the web page.

This can be done by using <ctrl> F searches or equivalent on the page, e.g., on "2.1" without the quotation marks

Happy searching/browsing!.

Phages (see section 2.1. Phages )

Source (2.1.1.)
Characterization (2.1.2.)
Genomics (2.1.3.)
Justification (2.1.4.)
Phage Stocks (2.1.5.)

Host Range (see section 2.2. Host Range )

Determination (2.2.1.)
Spot Testing (2.2.2.)
Tested Hosts (2.2.3.)
Cocktails (2.2.4.)

Formulated Products (see section 2.3. Formulated Products )

Purification (2.3.1.)
Purity (2.3.2.)
Dilution (2.3.3.)
Ingredients (2.3.4.)
Physical State (2.3.5.)
Processing (2.3.6.)
Disclosure (2.3.7.)

Titers (see section 2.4. Titers )

Assessment (2.4.1.)
Within-Formulation Information (2.4.2.)
Stability (2.4.3.)

Subjects (see section 2.5. Subjects )

Specifics (2.5.1.)
Health (2.5.2.)
Numbers (2.5.3.)

Bacteria (see section 2.6. Bacteria )

Strains (2.6.1.)
Preparation and Physiology (2.6.2.)
Concentrations (2.6.3.)
Challenge (2.6.4.)
Enumeration (2.6.5.)

Dosing (see section 2.7. Dosing )

Initiation (2.7.1.)
Numbers (2.7.2.)
Administration (2.7.3.)
Densities In Situ (2.7.4.)
Multiplicity of Infection (2.7.5.)
Prediction (2.7.6.)
Report Titers! (2.7.7.)

Treatment (see section 2.8. Treatment )

Preparation (2.8.1.)
Numbers of Doses (2.8.2.)
Frequency (2.8.3.)
Duration (2.8.4.)
Other (2.8.5.)

Pharmacology (see section 2.9. Pharmacology )

Pharmacokinetics (2.9.1.)
Toxicities (2.9.2.)

Efficacy (see section 2.10. Efficacy )

Results (2.10.1.)
Comparison (2.10.2.)
Activity (2.10.3.)

Discussions (see section 2.11. Discussion )

Comparisons (2.11.1.)
Limitations (2.11.2.)